1. Home
  3. ZeST - Immuno-oncology Game

ZeST - Immuno-oncology Game

£60.00 GBP exc. VAT
exc. VAT £60.00 GBP exc. VAT
Shipping calculated at checkout.
Version: ZeST online version- single annual licence

A version of the board game for use with TEAMS, ZOOM, SKYPE. 

In association with:

An educational board game to support health professionals involved in the management of patients who receive checkpoint inhibitor immunotherapy. 

Learn more about ZeST here

Add the board game to your order here
SKU:
Collections:
£60.00 GBP exc. VAT
exc. VAT £60.00 GBP exc. VAT

  • ZeST replicates the benefits of face-to-face games in a simple web-based tool that anyone can use. It does not require any training or special technology.

    ZeST games are designed to be played during group meetings on Zoom, Skype, TEAMS, WebEx. There is no direct link between ZeST and these meetings platforms. The facilitator just shares their ZeST screen with the group.

    The actual games are designed to be very simple to manage allowing the facilitator to concentrate on encouraging and maintaining group discussions.

    ZeST games will help you to recreate the energy and discussions you’d get during a face-to-face game.

    A single licence gives you unrestricted access to a specific game on the ZeST platform for 12 months. A single licence allows one online game session to be run at any time. However, you can invite as many participants as you wish to each session and you can organise as many back-to-back game sessions as you need. You can also purchase additional licenses.

  • As the use of immunotherapy, (IO), and particularly checkpoint inhibitors, (ICIs), is increasing at an exponential rate. The ability of healthcare teams to support patients on ICIs is important. This is increasingly relevant across haemato-oncological services, including pan-tumour teams and acute oncology. 

    However, supporting staff to implement news ways of working is challenging. There is a need for engaging and effective educational resources, that address this subject. It focuses on the recognition, investigation and management of immune related adverse events, (irAEs), secondary to checkpoint inhibitor therapy. The game encourages players to discuss and answer a series of questions, allowing them to acquire knowledge and understanding, share ideas and learn from each other. Peer discussions are what helps players to enhance their learning.

    The game will help clinicians to develop an understanding of areas including:

    • What is oncological immunotherapy 
    • Mechanisms of IO therapy
    • Types of IO therapy
    • What a patient journey looks like
    • Potential long-term impact of IO and associated toxicity
    • Episodic nature of toxicity
    • Management of toxicity and how this is evolving
    • Patient perception of risk and benefit
    • Short/Long term response
    • Personalised medication approach